Neurogene Inc. Other Current Assets
Neurogene Inc. (NGNE) had Other Current Assets of $132.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Current $132.00K.
- 2026-03-31: Other Assets, Current $181.00K.
- 2025-12-31: Other Assets, Current $168.00K.
- 2025-09-30: Other Assets, Current $208.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $132.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $181.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $168.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $208.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $970.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $997.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $981.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $1.60M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $1.53M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.25M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.09M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.39M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.72M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.20M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $630.00K 10-K · filed 2024-03-18 | $2.75M 10-K · filed 2023-03-20 |
| 2022-09-30 | $1.98M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.03M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.31M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.52M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.57M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.26M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.92M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.97M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $5.44M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.40M 10-Q · filed 2020-08-12 | |
| 2019-12-31 | $503.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |